Translations:Sitagliptin/9/en

Sitagliptin was developed by Merck & Co. and approved for medical use in the United States in 2006. In 2021, it was the 83rd most commonly prescribed medication in the United States, with more than 8 million prescriptions. It is available as a generic medication in Canada but not the United States.